Simeon H. Wall, Jr., MD – Trademark Portfolio

Entity Type: 99

Simeon H. Wall, Jr., MD holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 5 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include SL C SAFELIPO CORRECT, SL 360 SAFELIPO 360-DEFINITION, SL HD SAFELIPO HIGH-DEFINITION, and SL ES SAFELIPO EXCESSIVE SWEATING. The owner is based in Shreveport, LA.

The Wall Center for Plastic Surgery

Shreveport, LA 71105

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Simeon H. Wall, Jr., MD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (5 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Simeon H. Wall, Jr., MD have?

Simeon H. Wall, Jr., MD has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.

What trademark classes does Simeon H. Wall, Jr., MD file in?

Simeon H. Wall, Jr., MD files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are Simeon H. Wall, Jr., MD's most well-known trademarks?

Simeon H. Wall, Jr., MD's registered trademark portfolio includes well-known marks such as SL C SAFELIPO CORRECT, SL 360 SAFELIPO 360-DEFINITION, SL HD SAFELIPO HIGH-DEFINITION, and SL ES SAFELIPO EXCESSIVE SWEATING. These are among 4 currently registered trademarks in the portfolio.

What is Simeon H. Wall, Jr., MD's trademark registration success rate?

Simeon H. Wall, Jr., MD has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.